Hypertension: relationships between pathophysiology and therapy.
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000502:physiology; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001794:Blood Pressure; D002302:Cardiac Output; D002490:Central Nervous System / Q000187:drug effects; D002648:Child; D004231:Diuresis; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D006977:Hypertension, Renal / Q000503:physiopathology; D006978:Hypertension, Renovascular / Q000503:physiopathology; D009318:Natriuresis; D012083:Renin / Q000502:physiology; D014655:Vascular Resistance / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects; D000092502:Renin Inhibitors
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000804:Angiotensin II; D000959:Antihypertensive Agents; D004232:Diuretics; D012083:Renin; D000092502:Renin Inhibitors